Hollsteen
← MongoDB

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2016: −$229M · 10-K 0001441816-18-000028 filed Mar 30, 2018Equity incl. NCI · Q1 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2017: −$245M · 10-K 0001441816-19-000067 filed Apr 1, 2019Equity incl. NCI · Q1 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2018: $213M · 10-Q 0001441816-17-000010 filed Dec 15, 2017Equity incl. NCI · Q4 FY2018: $248M · 10-K 0001441816-19-000067 filed Apr 1, 2019Equity incl. NCI · Q1 FY2019: $229M · 10-Q 0001441816-19-000109 filed Jun 7, 2019Equity incl. NCI · Q2 FY2019: $269M · 10-Q 0001441816-19-000187 filed Sep 5, 2019Equity incl. NCI · Q3 FY2019: $266M · 10-Q 0001441816-19-000242 filed Dec 10, 2019Equity incl. NCI · Q4 FY2019: $265M · 10-K 0001441816-19-000067 filed Apr 1, 2019Equity incl. NCI · Q1 FY2020: $248M · 10-Q 0001441816-19-000109 filed Jun 7, 2019Equity incl. NCI · Q2 FY2020: $239M · 10-Q 0001441816-19-000187 filed Sep 5, 2019Equity incl. NCI · Q3 FY2020: $219M · 10-Q 0001441816-19-000242 filed Dec 10, 2019Equity incl. NCI · Q4 FY2020: $83.0M · 10-K 0001441816-20-000067 filed Mar 27, 2020Equity incl. NCI · Q1 FY2021: $63.0M · 10-Q 0001441816-20-000110 filed Jun 5, 2020Equity incl. NCI · Q2 FY2021: $48.0M · 10-Q 0001441816-20-000176 filed Sep 3, 2020Equity incl. NCI · Q3 FY2021: $22.0M · 10-Q 0001441816-20-000233 filed Dec 9, 2020Equity incl. NCI · Q4 FY2021: −$5.0M · 10-K 0001441816-21-000051 filed Mar 22, 2021Equity incl. NCI · Q1 FY2022: −$268M · 10-Q 0001441816-21-000095 filed Jun 4, 2021Equity incl. NCI · Q2 FY2022: $674M · 10-Q 0001441816-21-000192 filed Sep 3, 2021Equity incl. NCI · Q3 FY2022: $663M · 10-Q 0001441816-21-000242 filed Dec 8, 2021Equity incl. NCI · Q4 FY2022: $667M · 10-K 0001441816-22-000059 filed Mar 18, 2022Equity incl. NCI · Q1 FY2023: $673M · 10-Q 0001441816-22-000109 filed Jun 3, 2022Equity incl. NCI · Q2 FY2023: $668M · 10-Q 0001441816-22-000164 filed Sep 2, 2022Equity incl. NCI · Q3 FY2023: $684M · 10-Q 0001441816-22-000193 filed Dec 8, 2022Equity incl. NCI · Q4 FY2023: $740M · 10-K 0001441816-23-000027 filed Mar 17, 2023Equity incl. NCI · Q1 FY2024: $792M · 10-Q 0001441816-23-000087 filed Jun 2, 2023Equity incl. NCI · Q2 FY2024: $885M · 10-Q 0001441816-23-000168 filed Sep 1, 2023Equity incl. NCI · Q3 FY2024: $968M · 10-Q 0001441816-23-000248 filed Dec 7, 2023Equity incl. NCI · Q4 FY2024: $1.1B · 10-K 0001441816-24-000049 filed Mar 15, 2024Equity incl. NCI · Q1 FY2025: $1.3B · 10-Q 0001441816-24-000111 filed May 31, 2024Equity incl. NCI · Q2 FY2025: $1.4B · 10-Q 0001441816-24-000188 filed Aug 30, 2024Equity incl. NCI · Q3 FY2025: $1.5B · 10-Q 0001441816-24-000260 filed Dec 10, 2024Equity incl. NCI · Q4 FY2025: $2.8B · 10-K 0001441816-25-000057 filed Mar 21, 2025Equity incl. NCI · Q1 FY2026: $3.0B · 10-Q 0001441816-25-000118 filed Jun 4, 2025Equity incl. NCI · Q2 FY2026: $2.9B · 10-Q 0001441816-25-000181 filed Aug 27, 2025Equity incl. NCI · Q3 FY2026: $2.9B · 10-Q 0001628280-25-054768 filed Dec 2, 2025Equity incl. NCI · Q4 FY2026: $3.0B · 10-K 0001628280-26-016799 filed Mar 11, 2026Equity incl. NCI · Q1 FY2027: $2.9B · 10-Q 0001628280-26-039150 filed May 29, 2026Equity incl. NCI · Q2 FY2027: $3.0B · 10-Q 0001628280-26-059830 filed Sep 1, 20267922,980−2293,033Q1 FY2016Q2 FY2027Q1 FY2024
$MEquity incl. NCI · Q1 FY2023: $673M · 10-Q 0001441816-22-000109 filed Jun 3, 2022Equity incl. NCI · Q2 FY2023: $668M · 10-Q 0001441816-22-000164 filed Sep 2, 2022Equity incl. NCI · Q3 FY2023: $684M · 10-Q 0001441816-22-000193 filed Dec 8, 2022Equity incl. NCI · Q4 FY2023: $740M · 10-K 0001441816-23-000027 filed Mar 17, 2023Equity incl. NCI · Q1 FY2024: $792M · 10-Q 0001441816-23-000087 filed Jun 2, 2023Equity incl. NCI · Q2 FY2024: $885M · 10-Q 0001441816-23-000168 filed Sep 1, 2023Equity incl. NCI · Q3 FY2024: $968M · 10-Q 0001441816-23-000248 filed Dec 7, 2023Equity incl. NCI · Q4 FY2024: $1.1B · 10-K 0001441816-24-000049 filed Mar 15, 20247921,069673Q1 FY2023Q4 FY2024Q1 FY2024
Q1 FY2024
792$M
All values (38)
PeriodValue ($M)Status
Q2 FY20272,980reported
Q1 FY20272,935reported
Q4 FY20262,952reported
Q3 FY20262,888reported
Q2 FY20262,943reported
Q1 FY20263,033reported
Q4 FY20252,782reported
Q3 FY20251,502reported
Q2 FY20251,363reported
Q1 FY20251,269reported
Q4 FY20241,069reported
Q3 FY2024968reported
Q2 FY2024885reported
Q1 FY2024792reported
Q4 FY2023740reported
Q3 FY2023684reported
Q2 FY2023668reported
Q1 FY2023673reported
Q4 FY2022667reported
Q3 FY2022663reported
Q2 FY2022674reported
Q1 FY2022−268reported
Q4 FY2021−5reported
Q3 FY202122reported
Q2 FY202148reported
Q1 FY202163reported
Q4 FY202083reported
Q3 FY2020219reported
Q2 FY2020239reported
Q1 FY2020248reported
Q4 FY2019265reported
Q3 FY2019266reported
Q2 FY2019269reported
Q1 FY2019229reported
Q4 FY2018248reported
Q3 FY2018213reported
Q1 FY2018 – Q2 FY2018–missing (2 periods): No verified SEC value extracted, although the company reports this metric in other periods.
Q4 FY2017−245reported
Q1 FY2017 – Q3 FY2017–missing (3 periods): Grund wie bei Q1 FY2018 – Q2 FY2018.
Q4 FY2016Noneerror
Q1 FY2016 – Q3 FY2016–missing (3 periods): Grund wie bei Q1 FY2018 – Q2 FY2018.

Show reported periods only · CSV with all sources · Technical ID: equity_total

More metrics for MongoDB

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$792M
Period
Q1 FY2024, ended Apr 30, 2023 · as of Apr 30, 2023 (balance as of date, not a sum)
Source
10-Q, filed Jun 2, 2023 · 0001441816-23-000087
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$792MJun 2, 202310-Q 0001441816-23-000087reported · confidence 1. · current